Bronchiolitis Beyond the Emergency Department: A Retrospective Review of Home Nebulization, Readmission Rates, and Viral Factors Upon Discharge

Author Information

Abhishek Dutta, St. Christopher's Hospital for ChildrenFollow
Jeffrey Hernandez, Pediatric Emergency Department, St. Christopher's Hospital for ChildrenFollow
Robert Le, St. Christopher's Hospital for ChildrenFollow
Jean Marie Rinnan, Pediatric Emergency Department, St. Christopher's Hospital for ChildrenFollow
Luis Gamboa, Pediatric Emergency Department, St. Christopher's Hospital for Children, Philadelphia, Pennsylvania, USAFollow

Keywords:

Bronchiolitis, RSV, Readmission, Bronchodilator, Bounce-Back

Recommended Citation

REFERENCES Ralston SL, Lieberthal AS, Meissner HK, et al. Clinical practice guideline: the diagnosis, management, and prevention of bronchiolitis. Pediatrics. 2014;134(5):e1474-e1502. Gadomski AM, Scribani M. Bronchodilators for bronchiolitis. Cochrane Database Syst Rev. 2014;6(6):CD001266. Zhang L, Geng X, Zhang Q, Zhao M, Liu E. Bronchodilators for bronchiolitis: an updated systematic review and meta-analysis. Eur J Pediatr. 2024;[volume:pages]. Justice NA, Le JK. Bronchiolitis. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023. Published June 26, 2023. Accessed October 12, 2024. Erickson EN, Bhakta RT, Mendez MD. Pediatric bronchiolitis. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023. Published June 26, 2023. Accessed October 12, 2024. Norwood A, Mansbach JM, Clark S, Waseem M, Camargo CA. Prospective multicenter study of bronchiolitis: predictors of an unscheduled visit after discharge from the emergency department. Acad Emerg Med. 2010;17(4):372-378. Kook Y, Lee JS, Ryu J-M. Risk factors for acute bronchiolitis-related return visits to the Emergency Department. Pediatr Emerg Med J. 2022;9(2):64-69. Gómez-Ochoa SA, Rojas-Reyes MX. Viral etiology and risk factors for admission to the pediatric intensive care unit in children with acute bronchiolitis: a systematic review. Pediatr Pulmonol. 2020;[volume:pages]. Hasegawa K, Tsugawa Y, Mansbach JM, Camargo CA. Time from symptom onset to emergency department visit among children with bronchiolitis. Pediatrics. 2016;137(1):e20152431. Ploof DL, Kenyon CC, Li H, et al. Variations in the use of albuterol for bronchiolitis in U.S. children's hospitals. Pediatrics. 2015;135(5):804-811. Rodríguez-Martínez CE, Niño G, Castro-Rodríguez JA, Acuña-Cordero R, Sossa-Briceño MP, Midulla F. For which infants with viral bronchiolitis could it be deemed appropriate to use albuterol, at least on a therapeutic trial basis? Allergol Immunopathol (Madr). 2021;49(1):74-83. Niño G, Rodríguez-Martínez CE, Castro-Rodríguez JA. The use of B2-adrenoreceptor agonists in viral bronchiolitis: scientific rationale beyond evidence-based guidelines. Eur Respir Soc. 2020;6(4):00135-2020. Bottau P, Liotti L, Laderchi E, et al. Something is changing in viral infant bronchiolitis approach. Frontiers in Pediatrics. 2022;10:865977.

Institutional Review Board/Institutional Animal Care and Use Committee Approved or Exempt

IRB/IACUC approved